QUVIVIQ

QUVIVIQ is a prescription medicine brand offering daridorexant for adults who have trouble falling asleep or staying asleep due to insomnia. The brand describes its treatment as working differently from medicines that sedate the brain: it is thought to reduce overactive wake signals associated with insomnia. QUVIVIQ is intended to be taken nightly, within 30 minutes before bedtime, and only when the patient can remain in bed for at least seven hours, as directed by a healthcare provider.

The brand’s website provides information about how the medicine works and how to take it, along with frequently asked questions, resources, and patient sleep stories. It also offers a savings card for eligible commercially insured patients and an invitation to join Q&You for helpful tools and support. QUVIVIQ highlights clinical-study findings on sleep improvements over time, while emphasizing that results and risks should be discussed with a healthcare professional. The site includes prescribing information, a medication guide, and extensive safety information, including warnings about next-day drowsiness, impaired alertness, interactions, and other possible serious side effects.